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Context: Involvement of reactive oxygen species (ROS) in a variety of physiological and pathological processes has attracted a growing interest. In fact, identification of this global signaling system has provided new insights into underlying pathophysiological mechanisms of various diseases such as Alzheimer’s disease (AD). Understanding this information may lead to the development of novel therapeutic strategies.
Evidence Acquisitions: Limited efficacy of current medications for neurological disorders and dementias such as AD has led to considerable research interests in new drug development. Based on the modulatory effects of the Fenton reactions with transition metals such as iron, copper, zinc and aluminum on ROS and the effect of free radicals on neuroinflammatory and neurodegenerative processes, we hypothesized that pharmacological manipulation of the transition metals gated hydroxyl ion might be beneficial in treating neurological disorders such as AD.
Results: Catalytic activities of transition metals gated by the Fenton reactions are involved in the survival and pathological signaling pathways, neural plasticity, and neuroprotection. Furthermore, ROS and RNS have proved to exhibit overwhelming pathological effects leading to a variety of neurological disorders.
Conclusions: In the present investigation, an overview was made on regulatory role of the Fenton reaction gated catalytic activities of transition metals and some evidence regarding their mechanisms leading to Alzheimer’s disease. Based on the neuroinflammatory and neurodegenerative effects of transition metals, drugs with antagonizing effects could be a promising therapeutic alternative for Alzheimer’s disease.
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1. ContextThe Fenton and Haber Weiss reaction plays a significant role in oxidative stress causing numerous degenerative diseases such as Alzheimer’s disease (AD). Reactive oxy-gen species (ROS) and reactive nitrogen species (RNS) are produced by the reaction causing oxidative stress in AD. Iron, copper and aluminum promote the formation of free radicals such as Hydroxyl radicals causing dam-age to DNA, proteins, lipids and carbohydrates. Hydrox-yl radicals produced by Fenton reaction, causes the Aβ42 toxicity (1, 2) in AD. Hydroxyl radicals can be produced in the presence of Ferric ions and converts soluble hu-man fibrinogen into an insoluble fibrin- like aggregate observed in neurodegenerative diseases such as AD (3). DNA bases can be modified by the Fenton gated oxida-tive stress and base substitutions G→C (in the presence of Ferrous), G→T and C→T (Copper and Nickel) (4) by the reaction with ROS. Signal transduction molecules, such as extracellular signal-regulated kinase 1 and 2 (ERK1/2), c-Jun N -terminal kinase (JNK), phosphoinosit-ide 3- kinase (PI3K), p38 and transcription factors such as 
activator protein-1(AP-1), and p53 are activated by ROS (4, 5). Hydroxyl radicals can damage DNA by p53 pathway and accelerate AD development. Mutation in tumor sup-pressor gene (TP53) is associated with AD pathogenesis (2, 6). Oxidative stress is mainly produced by the Fenton re-action by removal of one electron from the molecular oxygen (O2) results in the formation of superoxide (O2-) which often produces other ROS species such as H2O2 and Peroxynitrite (ONOO)-and hydroxyl radicals (OH) (7). However under normal conditions, O2- has been emerged as an important signaling molecule, which controls specific biochemical reactions and metabolic processes (8). The link between O2- production and H2O2 can involve a reduced flavin enzyme, which transfers an electron to activate molecular oxygen into superoxide which either released or enzymatically converted into H2O2 (9, 10) or modified by drugs such as statins (11).One of the greatest challenges in the field of ROS-gated diseases is to bridge the knowledge gap between atomic 
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and cellular level, and more understanding of the Fen-ton reaction may help to bridge this gap. In 1890, Fenton used a solution of H2O2 and Iron to oxidized contami-nants of waste water. When transient metals such as iron react with hydrogen peroxide (H2O2), it produces Ferric (Fe +++), hydroxyl radical (OH-) and hydroxyl ion (OH-). Hydroxyl ion (OH-) reacts with H2O2 again to pro-duce superoxide (O2-) and hydroxyl ion (OH-).Reactive oxygen species (ROS) are produced as the by-product of the electron transport chain (ETC) in mito-chondria and are responsible for lipid peroxidation, protein oxidation, DNA damage and advanced glycation end-products (AGEs) formation via effects of ROS on cel-lular signaling pathways. 
2. Evidence Acquisitions
2.1. Oxidative Stress and ADOur early work on the effect of herbs on ROS (12-14) genes mutation in AD (15), effect of metals on gene modi-fication in psychiatric disorders (16) and effect of ROS on neurological disorders (17) indicate underlying impor-tance of the Fenton reaction. We searched any evidence (18-21) responsible for AD pathogenesis.
2.2. Fenton and Haber-Weiss ChemistrySince brain is the most aerobically active organ in the body, ROS is mostly produced in the brain. Iron (Fe), cop-per (Cu), zinc (Zn) and aluminum (Al), due to their mul-tiple valence states can react with the molecular oxygen and produce ROS and RNS. The Fenton and Haber-Weiss reaction has a significant role in ROS production and AD pathogenesis. The Fenton reaction is defined as the reac-tion of ferrous iron (Fe 2+) and hydrogen peroxide (H2O2). In this reaction, ferric iron (Fe 3+) and hydroxyl radical (OH.) are produced. Then hydroxyl radical (OH) reacts with H2O2 and superoxide (O2-) is produced. Then super-oxide reacts again with H2O2, hydroxyl radical (OH) and hydroxyl anion (-OH) are formed; this part of reaction is known as the “Haber-Weiss Reaction”. Superoxide (O2-) reduces to Fe 3+ rather than H2O2. The overall reaction is represented as follows;Fe 2+ + H2O2  Fe3+ + OH + -OH [Fenton reaction]OH + H2O2  O2- + H+ +H2OFe3+/Fe2+O2- +H2O2  OH. +OH- +O2 [Haber-Weiss reaction]Several metals such as Fe, Cu, Zn and Al have oxygen-transferring properties for the catalytic power to gener-
ate highly reactive •OH by the Fenton reaction. •OH is the 
most powerful oxidant for the oxidative stress in AD. •OH is mainly involved in three types of reaction as hydrogen abstraction, addition reaction and oxidation reaction.
R-H + •OH  R. + H2O [hydrogen abstraction reaction]R4C2 + •OH  R2–C (OH)-C.-(R) 2 [addition reaction]
Mn+ + •OH  Mn (n+1) + OH- [oxidation reaction]
2.3. Metals Causing Oxidative Stress in AD 
2.3.1. Iron in ADIron has a pivotal role in oxidative stress by the forma-tion of hydroxyl radical through Fenton reaction in AD pathogenesis. Fe2+ is oxidized to Fe3+ by oxygen molecule (O2), O2- is produced. O2- Reacts with hydrogen ion (H+) and H2O2 is produced. Then H2O2 reacts with Fe2+ and 
•OH is produced by the Fenton reaction. Then •OH is pro-duced again by the reaction of hydrogen peroxide in the presence of Fe3+/Fe2+ via the Haber-Weiss reaction.Lovell et al. in 1998 found that Fe concentration in AD plaques (~1 mmoL L-1) is more than normal brain tissue (~350µmol L-1) (22). In vitro studies also showed that Fe induces Aβ aggregation (23) and tau phosphorylation (24).
2.3.2. Copper in ADCopper (Cu) is also an important catalyst for production of ROS. Cu can bind with Aβ peptide, this Cu-Aβ peptide can produce H2O2 through reduction of Cu+2 to Cu+ and 
subsequently hydroxyl radical (•OH) is produced, which increases oxidative stress and causes neuronal death (25). Aβ is converted to Aβ; as a result Aβ exhibits the greatest activity of Aβ aggregation in AD pathogenesis (26). Aβ can also cause lipid protein oxidation and 4-hydroxy- 2-non-enal (HNE) carbonyl is produced.Cu2+ + Aβ Met (S)  Aβ Met (S+) + Cu+Cu+ + O2  Cu2+ + O2-O2-+ O2- + 2H+  H2O2Cu+ + H2O2  Cu2+ + •OH +-OH [Fenton reaction]Cu+2 + Aβ  Aβ. + Cu+Aβ. + lipid protein  HNE Carbonyl + AβActivity of cytochrome C- oxidase (27), copper/zinc per-oxidase (28) and ceruloplasmin (29) are diminished by free radicals. Lower level of ceruloplasmin may increase lipid peroxidation (30). Reduction of Cu+2 to Cu+ by Aβ en-
hances oxidative stress by the production of •OH and fur-ther neuronal damage in AD (31). Interaction of Cu with tau peptide may also induce neurofibrillary tangles (32). In vitro studies revealed that Cu2+ and Zn2+ promote neu-rotoxicity by the generation of H2O2 (33, 34). Literature indicated that Aβ-Cu2+ stimulates ROS production (33, 35) by the Fenton and Haber-Weiss reaction, causing oxida-tive stress and AD.
2.3.3. Zinc in ADZn binds to Aβ. Zn-Aβ complex is transiently stable prior to aggregation (36, 37) and contains less fibril (38). When Zn binds to Aβ-peptide via histidine residues, then Zn-Aβ complex changes their conformation and copper can-not bind to Aβ. In this way, Zn can prevent Cu-Aβ induced H2O2 and free radicals. The possible mechanism might be due to its competition with Cu or Fe. Low concentra-tion of Zn protects Aβ toxicity, but excessive Zn causes 
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neuronal death by the oxidation independently or syner-gistically. Higher concentration of Zn2+ binds to Aβ and precipitates at pH 6-8 (39).
2.3.4. Aluminum in ADAluminum (Al) can accelerate oxidative stress in vivo and in vitro (40). Aluminum superoxide semireduced radical ions (AlO22+) are produced by the reaction of Al3+ with superoxide (O2-). AlO22+ then reduces Fe3+ to Fe2+ and promotes the oxidative stress through the Fenton and Haber-Weiss reaction (41-43). 
2.4. DNA Damage 
Hydroxyl radical (•OH) plays a critical role in nucleic acids damage (44). It is produced by the Fenton reaction. 
•OH can react with DNA by either hydrogen abstraction or addition reaction. When hydroxyl radical reacts in hy-drogen abstraction, leading to disruption of DNA strand and when hydroxyl radical takes part in addition reac-tion, then deoxyguanosine is converted to 8-hydroxy de-oxyguanosine (8-OHdG) (45). OH + DNA  DNA strand breaks [hydrogen abstraction]5-hydroxymethyluracil and hydroxyadenine are pro-duced by the reaction of ROS with thymine and adenine respectively (46). In oxidative deamination, NH2 group is substituted by -OH group of Nucleic acid. As a result, adenine cytosine and guanine are transformed to hypo-xanthine, uracil and xanthine, respectively. Therefore, deamination of DNA can cause in GC → AT transition in oxidative stress (47, 48). Purine and pyrimidine bases can produce 20 different 
oxidative products of DNA with the interaction of •OH (49). 8-hydroxyguanine, 8-Hydroxyguanosine (8OHG), 8-hydroxyadenine, thymine glycol, Fapy-guanine, 5-hy-droxyuracil and Fapy-adenine are major products of DNA oxidation by the reaction of ROS and RNS (50) found in parietal, temporal, occipital, frontal lobe, superior tem-poral gyrus, hippocampus of brains of patients with AD (51). It is indicated that DNA damage is performed by the Fenton reaction in AD pathogenesis.
2.4. Lipid Peroxidation Due to the presence of double bonds, polyunsaturated fatty acid, is highly reactive towards free radicals mainly hydroxyl radical. Two reaction mechanisms are proposed for lipid peroxidation as hydroxyl radical dependent and hydroxyl independent. Fe2+ acts as a positive catalyst for the production of hydroxyl radical dependent lipid per-oxidation.Hydroxyl radical dependent mechanism:Fe2+ + H2O2  Fe3+ + •OH + -OH [The Fenton and Haber-Weiss reaction]Hydroxyl independent mechanism:Fe2+ + O2  [Fe2+-O2 ↔ Fe3+-O2.] → Fe3+ + O2-Fe3+ + O2-  O2 + Fe2+
Fe2+ + H2O2→ Fe2+O + H2OFe2++ Fe2+-O2  Fe2+-O2- Fe2+ →2 Fe2+-O2 Lipid (LH) peroxidation is performed by the following three steps (52);a)Initiation: 
LH +•OH  L. + H20b)Propagation:L. + O2  LOO.LOO. + LH  L. + LOOHLOOH  LO. + -OHc)Termination:L. + L.  L-LL. + LOO.  LOOLLOO. + LOO.  LOOL +O2Transition metals such as copper and iron can act as a positive catalyst in initiation and propagation steps of lipid peroxidation.Cu+ + LOOH  LO. + -OH +Cu2+Cu2+ + LOOH  LOO. + Cu+2LOOH  LO. + LOO. + H2OPolyunsaturated fatty acids (PUFAs) are mainly targeted by these radicals due to the presence of double bonds and produce polyunsaturated fatty acid-free radicals (LO. LOO). Malondialdehyde (MDA) is then produced by the cyclization reaction of end peroxides and peroxyl radicals (ROO.) (53, 54). 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA) as lipid peroxidation products are formed in mitochondria (Figure 1) (55).
Figure 1. OH + DNA → DNA Strand Breaks [Hydrogen Abstraction]
2.5. Protein OxidationFree amino acids and proteins are oxidized to corre-sponding aldehyde and carboxylic acid by hydroxyl and superoxide radicals (56) produced by the Fenton and Haber-Weiss reaction and are known as “metal-catalyzed-oxidation” (MCO) (57). Oximes are also produced by hy-drogen peroxide and the reaction is initiated by abstrac-
tion of α-H of amino acid by •OH and carbon-centered radical is formed, which reacts with superoxide radical, hydrogen peroxide and water, to produce carboxylic acid and aldehyde. The overall reaction is represented in Fig-ure 2.Oxidation of cysteine residues leads to the reversible formation of mixed disulfides between protein thiol groups and low molecular weight thiol, in particular GSH (56). Carbonyl groups are produced by protein oxidation 
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with ROS (58). Protein oxidation is catalyzed by Fe, Cu, and Al with H2O2 .i.e. the Fenton-type reaction. 2.6. Advanced Glycation End (AGEs) FormationThe Fenton and Haber-Weiss reactions play significant role in the formation of advanced glycation end products with OH- acting as a base. Aldehyde (-CHO) or ketone (-C = O) containing compounds such as glucose can react with amino group (-NH2) of proteins forming the “Schiff’s base”. Then the “Schiff’s base” rearranges to produce the “Amadori products” (Figure 3). These products are re-sponsible for the formation of advanced Glycation end-products (AGEs) through several types of reactions, such as rearrangement, dehydration, condensation, fragmen-tation, oxidation and cyclization reactions (59). High reactive carbonyl intermediates such as glyoxal, 3-deoxy-glucosome and methyl-glyoxal are produced by auto-oxidation of glucose, the Schiff’s base or the Amado-ri products. Then these products can also react with pro-tein free amino group and produce imidazolone, N-q-car-boxy-methyl-lysine (CML), N-q-carboxy-ethyl-lysine (CEL), glyoxal-lysine dimer (GOLD) and methyl-glyoxal-lysine 
dimer (MOLD) (60-64). AGEs accumulate both intra and extracellular of the aging brain, but in case of AD brain, more AGEs are found in plaque fractions responsible for Aβ, than control brain (65).
Figure 2. General Reaction Between Amino Acid and ROS Producing Hy-droxyl Radical, Superoxide Anion Radical (or Its Conjugated Acid, HO2.), Hydrogen Peroxide by Fenton and Haber-Weiss Reaction
In conclusion protein is converted into corresponding aldehyde, carbox-ylic acid and oxime by oxidation process.
Figure 3. The Mechanism of Amadori Rearrangement
Amadori product gains their stability by Enol-keto tautomerism. Here –OH acts as a base in this rearrangement. –OH is produced by The Fenton and Haber-Weiss reaction. Six types of AGEs are produced as glucose (AGE-1), carbohydrates like glyceraldehydes (AGE-2), dicarbonyls like glycolaldehyde (AGE-3), methylglyoxal (AGE-4) , glyoxal (AGE-5) and 3-deoxyglucosone (AGE-6) (60).
2.7. Effect of ROS on Signaling PathwaysROS is mainly produced by the Fenton and Haber-Weiss reactions and excess ROS can cause cell death through apoptosis in AD (66). ROS and Aβ can activate ASK1 sig-naling pathway. ASK1 activates “ASK1 Signalosome” by TNF receptor-associated factor (TRAF) 2 and 6 (67). Then it activates MKK 3/6 pathways, as a result JNK signaling pathway is activated leading to insulin resistance by serine phosphorylation of insulin receptor substrate 1 
(IRS 1). Brain imaging (68) revealed the presence of hy-poglycemia in Alzheimer’s disease (69-71). Glucose me-tabolism is regulated mainly by insulin signaling (72), but little is known about the role of insulin in the brain (73). JNK pathway can activate tau phosphorylation and neuronal cell-death (74) as well as inhibiting tyrosine phosphorylation of IRS-1, which results in further cogni-tive impairment in AD. 
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3. ResultsIt is now well established that ROS and RNS (Table 1) can damage different targeted biological molecules such as DNA, protein, lipid through Fenton gated oxidative stress. Figure 4 exhibits synergistic activity of iron and alumi-
num. Here we can see reduction of Fe3+ to Fe2+ by AlO22+, which promotes the oxidative stress through Fenton and Haber-Weiss reaction. Similarly, signaling molecules play essential role in conjunction with Fenton reaction in the pathogenesis of AD as shown in Figure 5.
Figure 4. Schematic Diagram for the Formation of Aluminum Superoxide Semireduced Radical Ion and Aluminum Superoxide Complex (43), Which Reduces Fe3+ to Fe2+ and Promotes Oxidative Stress by Hydroxyl Radical Formation Through the Fenton and Haber-Weiss Reaction.
Figure 5. Schematic Diagram of the ROS and RNS Production and Their Connectivity With ASK 1, MKK and JNK Signaling Pathway, Adopted From (66).
These pathways may create Insulin resistance and Alzheimer’s disease. ASK1 activates JNK and in a Raf-independent fashion in response to oxidative stress such as oxidative stress, ER stress.
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Table 1.  Reactive Oxygen and Nitrogen Species Which Enhance Oxidative Stress in Alzheimer’s disease (AD); Fe, Cu, Zn and Al Have Catalytic Activity for ROS Production by the Fenton and Haber-Weiss Reaction
Variable Value
A) Reactive oxygen spices (ROS)
RadicalSuperoxide (anion) O2•-  Carbonate (anion) CO3•-  Hydroperoxy HOO•  Hydroxyl HO  Hydroperoxyl HO2•  Peroxyl ROO•Alkoxyl RO•
Non-RadicalHydrogen Peroxide H2O2Singlet Oxygen 1O2Hypochlorous Acid HOClOzone O3
B) Reactive Nitrogen Spices(RNS)
Radical Nitrogen Monoxide •NONitrogen Dioxide •NO2
Non- RadicalPeroxynitrite (anion) ONOO–Peroxynitrous Acid ONOOHNitrosoperoxycarbonate (anion) ONOOCOO–Nitronium (Cation) +NO2Dinitrogen Trioxide N2O3
4. DiscussionMitochondrial dysfunction has a pivotal role in Alzheim-er’s disease. Production of reactive oxygen species is one of the main reasons of mitochondrial dysfunction. ROS can damage protein, lipid, DNA and can impair glucose metab-olism, which is interlinked with insulin signaling. There-fore, there could be an association between Alzheimer’s disease and diabetes mellitus. The Fenton and Haber-Weiss reaction should be focused for the treatment of neurode-generative diseases such as Alzheimer’s disease. Antioxi-dants, metal chelators and free radical scavengers are used for the treatment of AD, but new therapeutic medications could be developed for prevention and treatment of Fen-ton gated neurological disorders like AD.
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